- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Idelalisib – November 2015
Idelalisib: oral tablet, 100 mg, 150 mg, Zydelig® (follicular lymphoma)
Last updated
18 March 2016